TY - JOUR
T1 - Norovirus GII.4 and GII.7 capsid sequences undergo positive selection in chronically infected patients
AU - Hoffmann, Dieter
AU - Hutzenthaler, Martin
AU - Seebach, Judith
AU - Panning, Marcus
AU - Umgelter, Andreas
AU - Menzel, Helge
AU - Protzer, Ulrike
AU - Metzler, Dirk
N1 - Funding Information:
We thank Hermann Schätzl and Gerd Frösner for helping to establish Norvirus PCRs. We also thank the technicians of the Institute of Virology, Technische Universität München, as well as patients, nurses, and doctors for their support of this study. The study was partially funded by the “ Förderverein zur Bekämpfung der Viruskrankheiten ”.
PY - 2012/3
Y1 - 2012/3
N2 - Norovirus has become an important cause for infectious gastroenteritis. Particularly genotype II.4 (GII.4) has been shown to spread rapidly and causes worldwide pandemics. Emerging new strains evade population immunity and lead to high norovirus prevalence. Chronic infections have been described recently and will become more prevalent with increasing numbers of immunocompromized patients. Here, we studied norovirus evolution in three chronically infected patients, two genotypes II.4 and one II.7.A 719 and 757. nt region was analyzed for GII.4 and GII.7, respectively. This covers the entire hypervariable P2 domain of the VP1 capsid gene. Genetic variability at given and between different time points was assessed. Evolutionary adaptation was analyzed by Bayesian sampling of genealogies. This analysis clearly demonstrated positive selection rather than incidental drift for all three strains. The GII.7 and one GII.4 strain accumulated on average 5-9 mutations per 100. days, most of them non-synonymous. This is a much higher evolutionary rate than observed for noroviruses on a global level.Our data demonstrate that norovirus quasispecies are positively selected in chronically infected patients. The numbers of intraindividual amino acid mutations acquired in the capsid gene are similar to those separating consecutive GII.4 epidemic strains. Evolution in a given, chronically infected individual may thus generate novel genotypes at risk to expedite global evolution particularly for slowly evolving genotypes, as GII.7.
AB - Norovirus has become an important cause for infectious gastroenteritis. Particularly genotype II.4 (GII.4) has been shown to spread rapidly and causes worldwide pandemics. Emerging new strains evade population immunity and lead to high norovirus prevalence. Chronic infections have been described recently and will become more prevalent with increasing numbers of immunocompromized patients. Here, we studied norovirus evolution in three chronically infected patients, two genotypes II.4 and one II.7.A 719 and 757. nt region was analyzed for GII.4 and GII.7, respectively. This covers the entire hypervariable P2 domain of the VP1 capsid gene. Genetic variability at given and between different time points was assessed. Evolutionary adaptation was analyzed by Bayesian sampling of genealogies. This analysis clearly demonstrated positive selection rather than incidental drift for all three strains. The GII.7 and one GII.4 strain accumulated on average 5-9 mutations per 100. days, most of them non-synonymous. This is a much higher evolutionary rate than observed for noroviruses on a global level.Our data demonstrate that norovirus quasispecies are positively selected in chronically infected patients. The numbers of intraindividual amino acid mutations acquired in the capsid gene are similar to those separating consecutive GII.4 epidemic strains. Evolution in a given, chronically infected individual may thus generate novel genotypes at risk to expedite global evolution particularly for slowly evolving genotypes, as GII.7.
KW - Bayesian sampling
KW - Coalescent-based computation
KW - Genotypes
KW - Intraindividual evolution
KW - Norovirus
KW - Selection
UR - http://www.scopus.com/inward/record.url?scp=84857656297&partnerID=8YFLogxK
U2 - 10.1016/j.meegid.2012.01.020
DO - 10.1016/j.meegid.2012.01.020
M3 - Article
C2 - 22310302
AN - SCOPUS:84857656297
SN - 1567-1348
VL - 12
SP - 461
EP - 466
JO - Infection, Genetics and Evolution
JF - Infection, Genetics and Evolution
IS - 2
ER -